Advertisement
Canada markets close in 4 hours 40 minutes

  • S&P/TSX

    21,923.95
    +38.57 (+0.18%)
     

  • S&P 500

    5,098.52
    +50.10 (+0.99%)
     

  • DOW

    38,171.47
    +85.67 (+0.22%)
     

  • CAD/USD

    0.7306
    -0.0018 (-0.24%)
     

  • CRUDE OIL

    83.68
    +0.11 (+0.13%)
     

  • Bitcoin CAD

    87,252.62
    +281.41 (+0.32%)
     

  • CMC Crypto 200

    1,331.06
    -65.48 (-4.69%)
     

  • GOLD FUTURES

    2,345.40
    +2.90 (+0.12%)
     

  • RUSSELL 2000

    1,999.92
    +18.80 (+0.95%)
     

  • 10-Yr Bond

    4.6630
    -0.0430 (-0.91%)
     

  • NASDAQ

    15,925.60
    +313.84 (+2.01%)
     

  • VOLATILITY

    15.33
    -0.04 (-0.26%)
     

  • FTSE

    8,140.31
    +61.45 (+0.76%)
     

  • NIKKEI 225

    37,934.76
    +306.28 (+0.81%)
     

  • CAD/EUR

    0.6838
    +0.0017 (+0.25%)
     
MARKETS LIVE BLOG:

STOCKS RISE, LED BY STELLAR ALPHABET, MICROSOFT EARNINGS

Results from 'Magnificent Seven' duo show cloud revenue boosted by strong AI demand

Compared to Estimates, Health Catalyst (HCAT) Q1 Earnings: A Look at Key Metrics

Zacks Equity Research
·2 min read

For the quarter ended March 2023, Health Catalyst (HCAT) reported revenue of $73.87 million, up 8.5% over the same period last year. EPS came in at $0.05, compared to -$0.06 in the year-ago quarter.

The reported revenue compares to the Zacks Consensus Estimate of $71.16 million, representing a surprise of +3.81%. The company delivered an EPS surprise of +225.00%, with the consensus EPS estimate being -$0.04.

While investors scrutinize revenue and earnings changes year-over-year and how they compare with Wall Street expectations to determine their next move, some key metrics always offer a more accurate picture of a company's financial health.

Since these metrics play a crucial role in driving the top- and bottom-line numbers, comparing them with the year-ago numbers and what analysts estimated about them helps investors better project a stock's price performance.

ADVERTISEMENT

Here is how Health Catalyst performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

  • Revenue- Professional services: $26.68 million versus the seven-analyst average estimate of $25.97 million. The reported number represents a year-over-year change of +3.2%.

  • Revenue- Technology: $47.19 million versus $45.21 million estimated by seven analysts on average. Compared to the year-ago quarter, this number represents a +11.7% change.

  • Adjusted Gross Profit- Professional Services: $5.41 million versus $3.39 million estimated by seven analysts on average.

  • Adjusted Gross Profit- Technology: $32.96 million versus $31.13 million estimated by seven analysts on average.

View all Key Company Metrics for Health Catalyst here>>>

Shares of Health Catalyst have returned -5.1% over the past month versus the Zacks S&P 500 composite's +0.9% change. The stock currently has a Zacks Rank #2 (Buy), indicating that it could outperform the broader market in the near term.

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Health Catalyst, Inc. (HCAT) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research